GD
GSK icon

Grandfield & Dodd’s GSK GSK Stock Holding History

Grandfield & Dodd’s Portfolio GSK Stock Details GSK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q4 		– Sell
-5,837
Closed -$296K – 187
2017
Q3 		$296K Sell
5,837
-317
-5% -$16.1K 0.03% 160
2017
Q2 		$332K Sell
6,154
-180
-3% -$9.6K 0.04% 154
2017
Q1 		$334K Sell
6,334
-159
-2% -$8.07K 0.04% 151
2016
Q4 		$313K Sell
6,493
-1,092
-14% -$53.9K 0.04% 156
2016
Q3 		$409K Buy
7,585
+87
+1% +$4.77K 0.05% 132
2016
Q2 		$406K Sell
7,498
-640
-8% -$33.7K 0.06% 126
2016
Q1 		$413K Hold
8,138
– – 0.06% 117
2015
Q4 		$410K Sell
8,138
-1,775
-18% -$90.5K 0.06% 119
2015
Q3 		$476K Sell
9,913
-177
-2% -$9.21K 0.08% 108
2015
Q2 		$525K Buy
10,090
+41
+0.4% +$2.31K 0.08% 111
2015
Q1 		$580K Buy
10,049
+112
+1% +$6.42K 0.09% 100
2014
Q4 		$531K Sell
9,937
-482
-5% -$27K 0.08% 112
2014
Q3 		$599K Sell
10,419
-480
-4% -$29.4K 0.09% 101
2014
Q2 		$729K Hold
10,899
– – 0.11% 107
2014
Q1 		$728K Sell
10,899
-409
-4% -$27.6K 0.11% 105
2013
Q4 		$755K Hold
11,308
– – 0.12% 98
2013
Q3 		$709K Hold
11,308
– – 0.13% 101
2013
Q2 		$706K Buy
+11,308
New +$718K 0.13% 101

Other funds holding GSK

Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Hotchkis & Wiley Capital Management
Hotchkis & Wiley Capital Management Los Angeles, California $32.4B AUM 17.21% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Grandfield & Dodd's GSK Position: Q4 2017 in Review

Grandfield & Dodd sold out of GSK (GSK) in Q4 2017, closing a stake of 5,837 shares — an estimated $296K sold.

Grandfield & Dodd first reported a position in GSK in Q2 2013 and held it in 18 quarters. The position peaked at $755K in Q4 2013. 763 funds tracked by Wall St. Rank hold GSK as of Q4 2017.

  • Grandfield & Dodd reported no remaining GSK position as of Q4 2017 after selling out during the quarter.
  • Grandfield & Dodd sold 5,837 GSK shares in Q4 2017, an estimated $296K.
  • Grandfield & Dodd first reported a position in GSK in Q2 2013 and held it in 18 quarters.
  • Grandfield & Dodd's GSK position peaked at $755K in Q4 2013.
  • 763 funds tracked by Wall St. Rank held GSK as of Q4 2017.

Based on Grandfield & Dodd's 13F filing for Q4 2017, filed 6 Feb 2018.